Immune Checkpoint Inhibitors (ICI 2018)

Immune Checkpoint Inhibitors (ICI 2018) is a conference dedicated to the pathway biology and biomarker strategy in the development of your checkpoint drugs.

Topics

• Immuno-oncology combinations that deliver more robust and durable patient responses
• Discovery and validation of pathway biologies beyond PD-1
• The commercial strategy of the most advanced players and assess market opportunities for the year to come
• Novel biomarkers for patient stratification
• New preclinical models that effectively recapitulate the human immune system and improve predictability into the clinic
• Clinical strategies that support the rapid generation of trial data and support appropriate registrational paths
• Novel research on the TME, immune ecosystem and how these factors influence efficacy